Sentences with phrase «as myelodysplastic syndrome»
Children with SDS have a small but significant chance of developing blood disorders such as myelodysplastic syndrome (MDS) or leukemia.
http://www.danafarberbostonchildrens.org/ Not exact matches
The Arlington Heights Park District invites you to attend a special basketball fundraiser on Tuesday, January 15th in support of Bill Spicer who is bravely battling myelodysplastic syndrome (MDS, formerly known as preleukemia).
Already one epigenetic drug, 5 - azacytidine, has been approved by the Food and Drug Administration for use against myelodysplastic syndrome, also known as preleukemia or smoldering leukemia.
Inclusion Criteria: • Subject has a diagnosis of primary acute myeloid leukemia (AML) or AML secondary to myelodysplastic syndrome (MDS) according to WHO classification (2008) as determined by pathology review at the treating institute.
A Phase 1/2, Multicenter, Open - label Study of FT - 2102 as a Single Agent and in Combination with Azacitidine or Cytarabine in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome with an IDH1 Mutation
Rutgers Cancer Institute Recognized as a Center of Excellence for work with Myelodysplastic Syndromes Home News Tribune, MyCentralJersey.com — January 29, 2018
Inclusion Criteria: • Pathologically proven acute myeloid leukemia (AML) or intermediate, high - risk, or very high risk Myelodysplastic Syndrome (MDS) as defined by the World Health Organization (WHO) criteria or Revised International Prognostic Scoring System (IPSS - R) which is relapsed or refractory (R / R) to standard therapy and / or for which standard therapy is contraindicated or which has not adequately responded to standard therapy.
Currently, researchers are studying arsenic trioxide, as a single agent or in combination with other medicines, for treating myelodysplastic syndromes.
Our MDS center headed by Dr Amit Verma is recognized as a national «center of excellence» by the MDS Foundation and offers a variety of treatments and clinical trials for patients with Myelodysplastic syndromes.
Bone Marrow Failure and Myelodysplastic Syndrome Program The Bone Marrow Failure and Myelodysplastic Syndrome Program is recognized as one of the nation's best pediatric treatment and research programs for bone marrow failure, MDS and related conditions.
FDA Clears Test to Help Diagnose, Identify Blood Cancer Type: The FDA has approved ClearLLab Reagents (T1, T2, B1, B2, M) for the detection of hematologic malignancies such as acute and chronic leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, multiple myeloma, and non-Hodgkin lymphoma.